NCT01688531 - A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Acne

Interventions

DRUG

CD0271 0.1%/CD1579 2.5% gel

one application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months

DRUG

CD0271 0.1%/CD1579 2.5% gel vehicle

one application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months

Trial Locations (3)

Galderma Investigational site, Windsor

Galderma Investigational site, Montreal

Galderma Investigational site, Nantes